COVID-19 CONTRACTORS UPDATE Submit BEFORE 12 Noon TODAY
*** Please REMEMBER to complete and submit your weekly Community Pharmacy Sit Report BEFORE 12 NOON TODAY ***
COVID-19 CONTRACTORS UPDATE
LINK
Archives: Contractor Email
Dear Colleague
The following concessionary prices have been granted for January 2021:
| Drug | Pack Size | Concessionary Price |
| Ciprofloxacin 500mg tablets | 10 | £3.85 |
| Duloxetine 20mg gastro-resistant capsules | 28 | £8.68 |
| Duloxetine 30mg gastro-resistant capsules | 28 | £2.39 |
| Duloxetine 60mg gastro-resistant capsules | 28 | £3.99 |
| Enalapril 10mg tablets | 28 | £6.10 |
| Enalapril 20mg tablets | 28 | £10.10 |
| Esomeprazole 20mg gastro-resistant capsules | 28 | £3.99 |
| Lamotrigine 100mg tablets | 56 | £6.72 |
| Lamotrigine 200mg tablets | 56 | £8.13 |
| Lamotrigine 25mg tablets | 56 | £2.30 |
| Moxonidine 200microgram tablets | 28 | £8.70 |
| Moxonidine 300microgram tablets | 28 | £8.69 |
| Moxonidine 400microgram tablets | 28 | £7.50 |
| Ropinirole 1mg tablets | 84 | £26.99 |
| Sulfasalazine 500mg gastro-resistant tablets | 112 | £12.21 |
| Sulfasalazine 500mg tablets | 112 | £8.57 |
| Tamoxifen 20mg tablets | 30 | £10.21 |
| Zonisamide 100mg capsules | 56 | £59.00 |
This is the first update of concessionary prices for January 2021.
Concessionary prices will be paid against the usual code, no additional endorsements are needed.
Concessionary prices may be granted up until the end of the month so CPNI will notify you of any further concessionary prices as and when they are agreed.
Please continue to notify CPNI of any pricing issues you are experiencing via our new Medicines Shortage Reporter
Concessionary Prices are also published on the CPNI website.
Kind Regards,
SENT ON BEHALF OF GARETH C. GILVARY | Governance & Support Pharmacist
Dear Colleague
The Department of Health (NI) has asked us to make pharmacy contractors aware of the UK-wide Ask for ANI (Action Needed Immediately) Codeword Scheme which will be launched nationally in early January.
This domestic abuse codeword scheme is being established in pharmacies to enable victims of domestic abuse to access support within their community, from the safety of their local pharmacy.
Contractors wishing to participate in the scheme may access training materials and posters at the given links (Ask for ANI materials / Ask for ANI & Safe Spaces materials) and are asked to complete an online form to confirm their decision to provide the scheme and to ensure that staff watch the training animation and read the guidance.
Yours sincerely
Vanessa
SENT FOR AND BEHALF OF DR VANESSA CHAMBERS | Head of Policy & Development
DRUG ALERTS available here: BSO Communications (Drug Alerts)
SHORTAGES INFORMATION available here: BSO Shortages Information
Guidance on Shortages for Primary Care
Sancuso 3.1mg/24hr transdermal patches (MPS 2750)
Prednisolone 5mg Supp (RPH Pharmaceuticals) (MPS 2667)
Konakion MM (phytomenadione) 10mg/ml amps (MPS 2749)
OTHER INFORMATION
MHRA Yellow Card Reporting of side effects from COVID vaccines
Pharmacy team(s) can keep updated with drug alerts, shortages information and other information via CPNI’s Contractor Calendar or via the BSO website.
Please continue to notify CPNI of any pricing issues or supply problems you are experiencing via our new Medicine Shortage Reporter.
Please bring this to the attention of your pharmacy team(s).
Kind regards,
Kerry
SENT ON BEHALF OF KERRY GRIMES | Governance & Support Pharmacist
SAVE THE DATE Tuesday 26 January 2021 @ 7:30pm
Dear Colleague
Please see ‘Save the Date’ document below ahead of the next Echo Session, scheduled to take place on
Tuesday 26th January 2021 from 7.30pm to 9.00pm.
Please use the meeting ID and passcode below to access the meeting:
Meeting ID: 730 081 2723 Passcode : 888561
Please see below ECHO Attendee & Moodle Guidance Notes and Project ECHO Enhanced Security Measures.
An agenda will be issued shortly.
Please share this with your pharmacist(s).
Yours sincerely
SENT ON BEHALF OF GERARD GREENE | Chief Executive
Dear Colleague
The Department of Health has issued a letter reminding contractors, GPs and others of the need to comply with the requirements of the Falsified Medicines Directive (FMD).
SUMMARY
From 1 January 2021, medicines in Northern Ireland continue to be aligned with EU regulation and legislation as a requisite of the NI Protocol. This includes the requirement for NI to continue to comply with the Falsified Medicines Directive and to continue to verify and decommission medicines at the end point of supply.
ACTION
Contractors are reminded of the need to:
- Advise their teams of the continuing need to adhere to the requirements of FMD; and
- Ensure that the pharmacy is registered with SecureMed, and ensure that equipment and procedures are in place to facilitate compliance.
Further information is available on the CPNI website and at SecurMed.
Yours sincerely
Mike
SENT ON BEHALF OF PROF. MIKE MAWHINNEY|Head of Regulatory Affairs